Nitazoxanide
- Generic Name
- Nitazoxanide
- Brand Names
- Alinia, Busulfex
- Drug Type
- Small Molecule
- Chemical Formula
- C12H9N3O5S
- CAS Number
- 55981-09-4
- Unique Ingredient Identifier
- SOA12P041N
- Background
Nitazoxanide belongs to the class of drugs known as thiazolides. Nitazoxanide (NTZ) is a broad-spectrum anti-infective drug that markedly modulates the survival, growth, and proliferation of a range of extracellular and intracellular protozoa, helminths, anaerobic and microaerophilic bacteria, in addition to viruses. This drug is effective in the treatment o...
- Indication
用于治疗隐孢子虫、贾第鞭毛虫、阿米巴原虫引起的原虫性腹泻。
- Associated Conditions
- Diarrhea caused by Cryptosporidium parvum, Diarrhea caused by Giardia lamblia
- Associated Therapies
- -
Study of Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter Pylori
- First Posted Date
- 2015-04-21
- Last Posted Date
- 2017-04-25
- Lead Sponsor
- Sherief Abd-Elsalam
- Target Recruit Count
- 120
- Registration Number
- NCT02422706
- Locations
- 🇪🇬
Tanta university hospital, Cairo, Egypt
The Effects of Nitazoxanide in Hepatic Encephalopathy
- Conditions
- Interventions
- First Posted Date
- 2015-01-08
- Last Posted Date
- 2015-01-08
- Lead Sponsor
- Ain Shams University
- Target Recruit Count
- 36
- Registration Number
- NCT02334163
- Locations
- 🇪🇬
Faculty of medicine, Ain Shams University, Cairo, Egypt
Oral Nitazoxanide in Acute Gastroenteritis in Australian Indigenous Children
- First Posted Date
- 2014-06-18
- Last Posted Date
- 2024-02-08
- Lead Sponsor
- Telethon Kids Institute
- Target Recruit Count
- 216
- Registration Number
- NCT02165813
- Locations
- 🇦🇺
Alice Springs Hospital, Alice Springs, Northern Territory, Australia
🇦🇺Royal Darwin Hospital, Darwin, Northern Territory, Australia
Nitazoxanide Versus Placebo for the Treatment of Hospitalized Subjects With Severe Acute Respiratory Illness
- Conditions
- Interventions
- First Posted Date
- 2014-02-07
- Last Posted Date
- 2018-08-01
- Target Recruit Count
- 260
- Registration Number
- NCT02057757
- Locations
- 🇲🇽
Hospital Central Dr. Ignacio Morones Prieto, San Luis Potosi, Mexico
🇲🇽Instituto Nacional de Pediatria, Coyoacan, Mexico
🇲🇽Hospital General Dr. Aurelio Valdivieso, Oaxaca, Mexico
The Role Of Nitazoxanide, Interferon Alfa And Ribavirin In Treatment Of Hepatitis C Infected Type 2 Diabetic Patients
- Conditions
- Interventions
- First Posted Date
- 2013-01-17
- Last Posted Date
- 2013-09-20
- Lead Sponsor
- Services Institute of Medical Sciences, Pakistan
- Target Recruit Count
- 66
- Registration Number
- NCT01770483
- Locations
- 🇵🇰
Endocrinology and Diabetes management centre, Lahore, Punjab, Pakistan
Irritable Bowel Syndrome Evaluation and Treatment in Primary Care
- Conditions
- Interventions
- First Posted Date
- 2012-07-16
- Last Posted Date
- 2019-01-23
- Lead Sponsor
- American Academy of Family Physicians
- Target Recruit Count
- 61
- Registration Number
- NCT01641341
- Locations
- 🇺🇸
Baton Rouge Family Practice, Baton Rouge, Louisiana, United States
🇺🇸American Academy of Family Physicians-National Research Network, Leawood, Kansas, United States
🇺🇸Torrance Clinical Research, Lomita, California, United States
Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza
- Conditions
- Interventions
- First Posted Date
- 2012-06-01
- Last Posted Date
- 2018-03-29
- Lead Sponsor
- Romark Laboratories L.C.
- Target Recruit Count
- 1941
- Registration Number
- NCT01610245
- Locations
- 🇦🇺
Influence Study SIte, Nedlands, Western Australia, Australia
🇳🇿Influence Study Site, Christchurch Central, Christchurch, New Zealand
Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection
- First Posted Date
- 2012-02-08
- Last Posted Date
- 2015-01-14
- Lead Sponsor
- Juan Macías
- Target Recruit Count
- 45
- Registration Number
- NCT01529073
- Locations
- 🇪🇸
H.U. Valme, Seville, Spain
Efficacy Study of Nitazoxanide Suspension in the Treatment of Rotavirus Disease in Children
- Conditions
- Interventions
- First Posted Date
- 2011-04-05
- Last Posted Date
- 2011-04-05
- Lead Sponsor
- Romark Laboratories L.C.
- Target Recruit Count
- 100
- Registration Number
- NCT01328925
- Locations
- 🇪🇬
Cairo University Children's Hospital, Cairo, Egypt
Nitazoxanide for the Treatment of Prolonged Diarrhea in Children
- First Posted Date
- 2011-03-30
- Last Posted Date
- 2011-03-30
- Lead Sponsor
- Romark Laboratories L.C.
- Target Recruit Count
- 100
- Registration Number
- NCT01326338
- Locations
- 🇵🇪
Regional Hospital of Cajamarca, Cajamarca, Peru
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.